- Home
- JAMF vs ATAI Comparison
JAMF vs ATAI Comparison
Compare JAMF & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JAMF | ATAI |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | United States | Netherlands |
| Employees | 2595 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JAMF | ATAI |
|---|---|---|
| Price | $13.03 | $4.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $15.56 | $14.33 |
| AVG Volume (30 Days) | 1.3M | ★ 3.3M |
| Earning Date | 02-26-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $690,590,000.00 | $3,018,000.00 |
| Revenue This Year | $15.30 | $943.18 |
| Revenue Next Year | $9.17 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 12.28 | ★ 811.78 |
| 52 Week Low | $7.09 | $1.15 |
| 52 Week High | $16.12 | $6.75 |
Technical Indicators
Market Signals| Indicator | JAMF | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 75.87 | 45.44 |
| Support Level | $12.96 | $3.64 |
| Resistance Level | $13.02 | $4.19 |
| Average True Range (ATR) | 0.02 | 0.25 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 77.78 | 32.87 |
Price Performance
Historical ComparisonAbout JAMF Jamf Holding Corp.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.